Agios Pharmaceuticals Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Agios Pharmaceuticals Inc
TickerAGIO
CIK #0001439222
CUSIP00847X104
SectorLife Sciences - Pharmaceutical Preparations
Address38 Sidney Street 2Nd Floor, Cambridge, MA 02139
Source [EDGAR]
CIK Filing 2011 - 2025
[0001439222] 10-K
[0001439222] 10-Q
[0001439222] 3
[0001439222] 4
[0001439222] 5
[0001439222] 8-K
[0001439222] SC 13D
[0001439222] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Bellevue Group AG Agios Pharmaceuticals Inc [2025-07-07] 0.0
Farallon Capital Partners LP Agios Pharmaceuticals Inc [2023-11-09] 0.6
Armistice Capital LLC Agios Pharmaceuticals Inc [2023-02-14] 5.01
Rock Springs Capital Management LP Agios Pharmaceuticals Inc [2023-02-14] 5.45
Price T Rowe Associates Inc /MD/ Agios Pharmaceuticals Inc [2022-02-14] 5.3
State Street Corp Agios Pharmaceuticals Inc [2022-02-09] 5.51
JPMorgan Chase & Co Agios Pharmaceuticals Inc [2022-01-19] 5.7
BlackRock Inc Agios Pharmaceuticals Inc [2020-02-07] 5.8
BlackRock Inc Agios Pharmaceuticals Inc [2018-02-01] 5.8
Vanguard Group Inc Agios Pharmaceuticals Inc [2017-02-09] 5.87
BlackRock Inc Agios Pharmaceuticals Inc [2017-01-30] 5.1
Capital International Investors Agios Pharmaceuticals Inc [2016-02-12] 5.7
Vanguard Specialized Funds Agios Pharmaceuticals Inc [2016-02-09] 6.7
Capital World Investors Agios Pharmaceuticals Inc [2015-02-13] 8.4
Wellington Management Group LLP Agios Pharmaceuticals Inc [2015-02-12] 5.5
BB Biotech AG Agios Pharmaceuticals Inc [2014-09-11] 5.1
Third Rock Ventures LP Agios Pharmaceuticals Inc [2014-02-12] 17.9
Flagship Ventures Fund 2007 LP Agios Pharmaceuticals Inc [2014-02-10] 12.4
Arch Venture Fund VII LP Agios Pharmaceuticals Inc [2014-02-06] 12.4
FMR LLC Agios Pharmaceuticals Inc [2013-11-12] 0.0
Celgene European Investment Co LLC Agios Pharmaceuticals Inc [2013-08-06] 13.3
Form 3/4/5 Filer 2011 - 2025
Agios Pharmaceuticals Inc
Smith Cynthia
Ballal Rahul D.
Goff Brian
Scadden David
Gheuens Sarah
Backstrom Jay T.
Jones Cecilia
Burns James William
Milanova Tsveta
Ho Maykin
Capello Jeffrey D
Foster-Cheek Kaye I
Fouse Jacqualyn A
Owen Adams Catherine
Viswanadhan Krishnan
Washburn Theodore James Jr.
Schenkein David P
Maraganore John
Poddar Richa
Clancy Paul J
Clark Ian T
Biller Jonathan
Car Bruce
Alenson Carman
Bowden Christopher
Miles Darrin
Hirsch Andrew
Celgene European Investment Co LLC
Celgene Alpine Investment Co., LLC
Celgene Switzerland LLC
Celgene Corp /DE/
Biller Scott
Hoerter Steven L.
Cantley Lewis Clayton Jr.
Nelsen Robert
Cole Douglas G.
Tessier-Lavigne Marc
Goddard Glenn
Higgons John Duncan
Karsen Perry A
ARCH Venture Partners VII, LLC
Crandell Keith
ARCH Venture Fund VII, L.P.
ARCH Venture Partners VII, L.P.
Bybee Clinton
Third Rock Ventures LP
TRV GP LLC
Third Rock Ventures GP, L.P.
Starr Kevin P
Flagship Ventures Fund 2007, L.P.
Kania Edwin M Jr
Afeyan Noubar
Flagship Ventures 2007 General Partner LLC
Mak Tak W.
Form 13F Holdings
Firm Period DFND Voting Shares
Farallon Capital Management LLC [2025-06-30] OTR 5,767,466 5,767,466
Vanguard Group Inc [2025-06-30] SOLE 0 5,576,349
BlackRock, Inc. [2025-06-30] SOLE 4,668,003 4,833,760
Bellevue Group AG [2025-06-30] DFND 3,590,150 3,590,150
Erste Asset Management GmbH [2025-06-30] SOLE 2,326,489 2,326,489
Commodore Capital LP [2025-06-30] SOLE 2,325,000 2,325,000
State Street Corp [2025-06-30] DFND 1,781,985 1,951,113
Macquarie Group Ltd [2025-06-30] SOLE 1,850,988 1,900,596
Geode Capital Management LLC [2025-06-30] DFND 1,405,755 1,405,755
Frazier Life Sciences Management LP [2025-06-30] SOLE 1,279,754 1,279,754
Armistice Capital LLC [2025-06-30] SOLE 1,168,000 1,168,000
Citadel Advisors LLC [2025-06-30] DFND 1,145,570 1,145,570
Paradigm Biocapital Advisors LP [2025-06-30] SOLE 1,142,511 1,142,511
Bank of America Corp /DE/ [2025-06-30] DFND 10,787 1,120,308
Caligan Partners LP [2025-06-30] SOLE 1,071,258 1,071,258
Dimensional Fund Advisors LP [2025-06-30] SOLE 1,024,811 1,046,681
JPMorgan Chase & Co [2025-06-30] DFND 917,690 1,027,417
Rock Springs Capital Management LP [2025-06-30] SOLE 989,745 989,745
Deutsche Bank AG [2025-06-30] DFND 883,468 921,586
Fisher Asset Management LLC [2025-06-30] DFND 530,666 877,540
Adage Capital Partners GP LLC [2025-06-30] SOLE 791,000 791,000
TCG Crossover Management LLC [2025-06-30] SOLE 697,003 697,003
Marshall Wace LLP [2025-06-30] OTR 0 684,669
ArrowMark Colorado Holdings LLC [2025-06-30] SOLE 658,691 658,691
Goldman Sachs Group Inc [2025-06-30] DFND 647,837 648,061
SCS Capital Management LLC [2025-06-30] SOLE 604,085 604,085
D. E. Shaw & Co., Inc. [2025-06-30] DFND 594,538 596,202
OrbiMed Advisors LLC [2025-06-30] DFND 144,100 557,900
Northern Trust Corp [2025-06-30] DFND 546,208 547,490
Connor Clark & Lunn Investment Management Ltd [2025-06-30] SOLE 505,225 505,225
Prev | Page 1 | Next
Terms | Privacy | Guide
tony@aum13f.com